SC
ETNB

Stempoint Capital’s 89bio ETNB Stock Holding History

Stempoint Capital’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-545,800
Closed -$4.27M – 66
2024
Q4 		$4.27M Buy
+545,800
New +$4.49M 1.07% 33
2024
Q1 		– Sell
-408,257
Closed -$4.56M – 72
2023
Q4 		$4.56M Buy
+408,257
New +$3.75M 1.22% 33

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stempoint Capital's ETNB Position: Q1 2025 in Review

Stempoint Capital sold out of 89bio (ETNB) in Q1 2025, closing a stake of 545,800 shares — an estimated $4.27M sold.

Stempoint Capital first reported a position in ETNB in Q4 2023 and held it in 2 quarters. The position peaked at $4.56M in Q4 2023. 186 funds tracked by Wall St. Rank hold ETNB as of Q1 2025.

  • Stempoint Capital reported no remaining 89bio position as of Q1 2025 after selling out during the quarter.
  • Stempoint Capital sold 545,800 89bio shares in Q1 2025, an estimated $4.27M.
  • Stempoint Capital first reported a position in 89bio in Q4 2023 and held it in 2 quarters.
  • Stempoint Capital's 89bio position peaked at $4.56M in Q4 2023.
  • 186 funds tracked by Wall St. Rank held 89bio as of Q1 2025.

Based on Stempoint Capital's 13F filing for Q1 2025, filed 15 May 2025.